跳至主要内容
临床试验/CTRI/2008/091/000206
CTRI/2008/091/000206未知不适用

A clinical trial of surgical treatment of Type2 Diabetes in non morbidly obese patients.

Self1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 待定
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Reduction or Stoppage of anti-diabetic medication

研究概览

简要总结

This study is a single arm trial to evaluate efficacy of sleeve gastrectomy with ileal transposition surgery on control of type 2 diabetes mellitus. The study will be conducted at Bombay Hospital, Mumbai in 100 patients. Primary outcome will be to assess reduction/stoppage of anti-diabetic medication in 3 months - 6 months. Secondary outcome will measure glycosylated hemoglobin A1C levels <6.5 at 6 months & 12 months after surgery.

研究设计

分配方式
Not Applicable
盲法
Not Applicable

入排标准

入选标准

  • 1.Diagnosed Type 2 Diabetes for 1-5 years
  • Poorly controlled blood sugar despite standard of care as demonstrated by HbA1C 8-11 & 3 office visits
  • BMI between 23.0 and
  • Stable weight as determined by no more than a 3% change in body weight in the last 3 months.
  • Age between 25 and 65(both men & women will be included)
  • Able to provide Informed Consent.
  • Able to comply with follow-up procedures.

排除标准

  • Previous history of major abdominal surgery which may lead to a hostile abdomen.
  • Patients who have an incurable malignant or debilitating disease.4.Serious uncorrectable impairment of coagulation (INR>1.4, PTT > + 3 secs), lungs, kidney or heart5.Diagnosed severe eating disorder6.Untreated endocrine disorder7.Active peptic ulcer8.Untreated H.
  • pylori9.Cognitive Impairment10.Diabetic autonomic neuropathy11.Symptomatic gastroparesis.

结局指标

主要结局

Reduction or Stoppage of anti-diabetic medication

时间窗: 3 months & 6 months

次要结局

  • Glycemic Control with HbA1C < 6.5(6 months & 12 months)

研究者

发起方
Self

研究点 (1)

Loading locations...

相似试验